+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Hematological Drugs Market Research Reports

Hemophilia B - Market Insight, Epidemiology and Market Forecast -2032 - Product Thumbnail Image

Hemophilia B - Market Insight, Epidemiology and Market Forecast -2032

  • Report
  • January 2022
  • 200 Pages
  • Global
From
Hemophilia - Epidemiology Forecast to 2032 - Product Thumbnail Image

Hemophilia - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Cold Agglutinin Disease (CAD) - Epidemiology Forecast to 2032 - Product Thumbnail Image

Cold Agglutinin Disease (CAD) - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Immune Thrombocytopenia (ITP) - Epidemiology Forecast to 2032 - Product Thumbnail Image

Immune Thrombocytopenia (ITP) - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Essential Thrombocythemia - Epidemiology Forecast to 2032 - Product Thumbnail Image

Essential Thrombocythemia - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Hemlibra (Emicizumab-kxwh) - Drug Insight and Market Forecast - 2030 - Product Thumbnail Image

Hemlibra (Emicizumab-kxwh) - Drug Insight and Market Forecast - 2030

  • Report
  • August 2020
  • 80 Pages
  • Global
From
Nplate (Romiplostim) Romiplate - Drug Insight and Market Forecast - 2030 - Product Thumbnail Image

Nplate (Romiplostim) Romiplate - Drug Insight and Market Forecast - 2030

  • Report
  • August 2020
  • 80 Pages
  • Global
From
Sickle Cell Disease Treatment Market Size and Forecasts 2020 - 2030, Global and Regional Share, Trends, and Growth Opportunity Analysis By Treatment, Route of Administration, and Distribution Channel - Product Thumbnail Image

Sickle Cell Disease Treatment Market Size and Forecasts 2020 - 2030, Global and Regional Share, Trends, and Growth Opportunity Analysis By Treatment, Route of Administration, and Distribution Channel

  • Report
  • November 2023
  • 245 Pages
  • Global
From
Malaria and Sickle Cell Disease Treatment Market Size and Forecasts 2020 - 2030, Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Treatment, Route of Administration, and Distribution Channel - Product Thumbnail Image

Malaria and Sickle Cell Disease Treatment Market Size and Forecasts 2020 - 2030, Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Treatment, Route of Administration, and Distribution Channel

  • Report
  • November 2023
  • 420 Pages
  • Global
From
Low Molecular Weight Heparin Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Enoxaparin, Dalteparin, Tinzaparin, Fraxiparine, Nadroparin, and Others), Packaging (Multi-Vials and Prefilled Syringes), Application , and End User, and Geography - Product Thumbnail Image

Low Molecular Weight Heparin Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Enoxaparin, Dalteparin, Tinzaparin, Fraxiparine, Nadroparin, and Others), Packaging (Multi-Vials and Prefilled Syringes), Application , and End User, and Geography

  • Report
  • December 2021
  • 191 Pages
  • Global
From
Blood Brain Barrier Technologies Market Forecast to 2028 - COVID-19 Impact and Global Analysis - Product Thumbnail Image

Blood Brain Barrier Technologies Market Forecast to 2028 - COVID-19 Impact and Global Analysis

  • Report
  • October 2021
  • 157 Pages
  • Global
From
Hemophilia B Patient Pool Analysis, Market Size and Market Forecast APAC - 2034 - Product Thumbnail Image

Hemophilia B Patient Pool Analysis, Market Size and Market Forecast APAC - 2034

  • Report
  • February 2024
  • 120 Pages
  • Asia Pacific
From
Hemophilia A Patient Pool Analysis, Market Size and Market Forecast APAC - 2034 - Product Thumbnail Image

Hemophilia A Patient Pool Analysis, Market Size and Market Forecast APAC - 2034

  • Report
  • February 2024
  • 120 Pages
  • Asia Pacific
From
Antiphospholipid Syndrome (APS) - Market Insight, Epidemiology and Market Forecast - 2034 - Product Thumbnail Image

Antiphospholipid Syndrome (APS) - Market Insight, Epidemiology and Market Forecast - 2034

  • Report
  • June 2024
  • 200 Pages
  • Global
From
Thrombotic Microangiopathy (TMA) - Market Insight, Epidemiology and Market Forecast - 2034 - Product Thumbnail Image

Thrombotic Microangiopathy (TMA) - Market Insight, Epidemiology and Market Forecast - 2034

  • Report
  • June 2024
  • 200 Pages
  • Global
From
Hypoxia - Market Insight, Epidemiology and Market Forecast - 2034 - Product Thumbnail Image

Hypoxia - Market Insight, Epidemiology and Market Forecast - 2034

  • Report
  • June 2024
  • 200 Pages
  • Global
From
Coagulation Factor Deficiency - Market Insight, Epidemiology and Market Forecast - 2034 - Product Thumbnail Image

Coagulation Factor Deficiency - Market Insight, Epidemiology and Market Forecast - 2034

  • Report
  • June 2024
  • 200 Pages
  • Global
From
Erythropoietic Protoporphyria - Market Insight, Epidemiology and Market Forecast - 2034 - Product Thumbnail Image

Erythropoietic Protoporphyria - Market Insight, Epidemiology and Market Forecast - 2034

  • Report
  • June 2024
  • 200 Pages
  • Global
From
Anemia In Chronic Kidney Disease - Market Insight, Epidemiology and Market Forecast - 2034 - Product Thumbnail Image

Anemia In Chronic Kidney Disease - Market Insight, Epidemiology and Market Forecast - 2034

  • Report
  • June 2024
  • 200 Pages
  • Global
From
Hyperuricemia - Market Insight, Epidemiology and Market Forecast - 2034 - Product Thumbnail Image

Hyperuricemia - Market Insight, Epidemiology and Market Forecast - 2034

  • Report
  • June 2024
  • 200 Pages
  • Global
From
Loading Indicator

The Hematological Drugs market is a segment of the pharmaceutical industry that focuses on the development and production of drugs used to treat hematological diseases. These diseases include anemia, leukemia, lymphoma, and other blood disorders. Hematological drugs are used to treat a variety of conditions, including cancer, autoimmune diseases, and blood disorders. The hematological drugs market is composed of a variety of companies, including large pharmaceutical companies, biotechnology companies, and specialty drug companies. These companies develop and produce drugs to treat hematological diseases, as well as other conditions. Some of the major players in the hematological drugs market include AbbVie, Amgen, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. Show Less Read more